Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TTRE: TTR Technologies, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (118)	8/19/2003 8:09:23 PM
From: afrayem onigwecher	Respond to of 120

TTR Technologies Appoints Judah Feigenbaum to Board of Directors Tuesday August 19, 4:10 pm ET NEW YORK--(BUSINESS WIRE)--Aug. 19, 2003--TTR TECHNOLOGIES, INC., (OTC BB: TTRE) announced today the appointment of Judah Marvin Feigenbaum to its Board of Directors and the resignations of Richard Gottehrer and Joel Schoenfeld from its Board of Directors. Judah Marvin Feigenbaum, 53, is the Chief Executive Officer of Acolyte Technologies Corporation ("Acolyte"), a company that develops patented technologies in the L.E.D. (light-emitting diode) field. Prior to joining Acolyte, Mr. Feigenbaum was the founder, President and Chief Executive Officer of The Patient Discharge Desk, a company that develops proprietary software for the health care industry. In the ten years prior to founding The Patient Discharge Desk, Mr. Feigenbaum was Chairman, President and Chief Executive Officer of United Diagnostics, Analytical Biosystems Corporation, Medical Science Institute, Physicians Clinical Laboratory, Inc. and NTBM Billing Services. Prior to that, Mr. Feigenbaum was Managing Partner, Chairman and Chief Executive Officer of Temco Home Health Care Products, Inc., a manufacturer of home health care and rehabilitation equipment. Richard Gottehrer and Joel Schoenfeld will be resigning from the Company's Board of Directors, effective August 28, 2003, for personal reasons, including focusing on other business opportunities and projects. The Company thanked both directors for their contributions to the Company and wished them well in their future endeavors. biz.yahoo.com